Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00482911
What this trial is testing

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival Neoplasm
National Institutes of Health Clinical Center (CC) 12
Testing effectiveness (Phase 2)Looking for participantsNCT06506643
What this trial is testing

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

Who this might be right for
CLLSolid Tumor, Adult
Vector Vitale LLC 36
Early research (Phase 1)Study completedNCT00004148
What this trial is testing

Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT01904123
What this trial is testing

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaRecurrent Brain Neoplasm+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT01026324
What this trial is testing

Dinaciclib in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Testing effectiveness (Phase 2)Study completedNCT01363206
What this trial is testing

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma

Who this might be right for
Malignant Melanoma, Metastatic
Lynn E. Spitler, MD 29
Testing effectiveness (Phase 2)Study completedNCT00513604
What this trial is testing

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental+1 more
National Cancer Institute (NCI) 158
Early research (Phase 1)UnknownNCT03068624
What this trial is testing

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal Melanoma
M.D. Anderson Cancer Center 34
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Not applicableStudy completedNCT03879395
What this trial is testing

Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study

Who this might be right for
Melanoma Stage IvMelanoma MetastaticAbdominal Tumor
Vastra Gotaland Region 15
Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Not applicableLooking for participantsNCT04068155
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Who this might be right for
Skin CancerCutaneous TumorCutaneous Metastasis
Alpha Tau Medical LTD. 80
Testing effectiveness (Phase 2)Study completedNCT02076633
What this trial is testing

Intratumoral Administration of L19IL2/L19TNF

Who this might be right for
Malignant Melanoma, Skin
Philogen S.p.A. 21
Testing effectiveness (Phase 2)Study completedNCT00204594
What this trial is testing

Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 1
Testing effectiveness (Phase 2)Looking for participantsNCT03563729
What this trial is testing

Melanoma Metastasized to the Brain and Steroids

Who this might be right for
Malignant Melanoma
Inge Marie Svane 80
Testing effectiveness (Phase 2)Study completedNCT00835419
What this trial is testing

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression

Who this might be right for
Melanoma
Piramal Enterprises Limited 12
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01705392
What this trial is testing

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Who this might be right for
Metastatic Malignant MelanomaUnresectable Malignant Melanoma
Haukeland University Hospital 2
Testing effectiveness (Phase 2)Study completedNCT00383292
What this trial is testing

Tasisulam in Treating Participants With Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Eli Lilly and Company 130
Next Page